Skip to main content
Cancer Biology & Therapy logoLink to Cancer Biology & Therapy
. 2014 Apr 23;15(5):651. doi: 10.4161/cbt.28966

Correction

Yang L, et al., “Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity”, Cancer Biol Ther 2014; 15:61–8

Lifang Yang 1,2,*, Zhijie Xu 1, Liyu Liu 1, Xiangjian Luo 1, Jingchen Lu 1, Lunquan Sun 2, Ya Cao 1,*
PMCID: PMC4026088

In the final submission of high-resolution figures for this manuscript’s publication, the image of the LMP1/CON in Figure 5 was inadvertently replaced with image of hTERT/CON. The published version of Figure 5 is therefore incorrect. The corrected version of the figure is shown below. The only change is in the panels of LMP1/CON in Figure 5; the rest of the figure is identical to the published version. We apologize for this oversight and for any confusion that it has caused.

graphic file with name cbt-15-651-g1.jpg

The corrected figure is shown here.

Yang L, Xu Z, Liu L, Luo X, Lu J, Sun L, Cao Y. Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity. Cancer Biol Ther. 2014;15:61–8. doi: 10.4161/cbt.26606.

Footnotes


Articles from Cancer Biology & Therapy are provided here courtesy of Taylor & Francis

RESOURCES